Cargando…
Xiaoyaosan (Tiaogan-Liqi therapy) protects peritoneal macrophages from corticosterone-induced stress by regulating the interaction between glucocorticoid receptor and ABCA1
BACKGROUND: Previous studies have reported that Xiaoyaosan (XYS), Tiaogan-Liqi therapy, has a protective function in depressive disorder, and can regulate body weight and corticosterone (CORT) level. However, little is known about the effect of XYS in treating atherosclerosis. This study aimed to ex...
Autores principales: | Chen, Mingtai, Huang, Ruolan, Fu, Wenjun, Ou, Lijun, Men, Ling, Zhang, Zhong, Yang, Shudong, Liu, Qiang, Luan, Jienan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7729347/ https://www.ncbi.nlm.nih.gov/pubmed/33313251 http://dx.doi.org/10.21037/atm-20-6505 |
Ejemplares similares
-
Investigating the mechanisms of Modified Xiaoyaosan (tiaogan-liqi prescription) in suppressing the progression of atherosclerosis, by means of integrative pharmacology and experimental validation
por: Chen, Mingtai, et al.
Publicado: (2021) -
Effectiveness and safety of Tiaogan formula in the treatment of coronary heart disease: A protocol for systematic review and meta-analysis
por: Mingtai, Chen, et al.
Publicado: (2022) -
Effectiveness and safety of Baduanjin exercise (BDJE) on heart failure with preserved left ventricular ejection fraction (HFpEF): A protocol for systematic review and meta-analysis
por: Chen, Mingtai, et al.
Publicado: (2020) -
Efficacy and safety of Zhibitai in treating coronary heart disease patients with hyperlipemia: A protocol for systematic review and meta-analysis
por: Chen, Mingtai, et al.
Publicado: (2020) -
Effectiveness and safety of Xinkeshu on coronary artery disease patients combined with anxiety and depression symptoms after percutaneous coronary intervention: A protocol for systematic review and meta-analysis
por: Chen, Mingtai, et al.
Publicado: (2021)